A clinical trial with DSIP.
In an open study 7 patients with severe insomnia were treated by a series of 10 injections with the delta-sleep-inducing peptide (DSIP). In all but 1 case sleep was normalized for follow-up periods of 3-7 months. The mood and performance during the daytime improved as well. A problem may be a long-standing habit of drug addiction.
D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003701:Delta Sleep-Inducing Peptide; D005260:Female; D006261:Headache / Q000150:complications; D006801:Humans; D006993:Hypnotics and Sedatives; D014854:Lateral Medullary Syndrome / Q000150:complications; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000627:therapeutic use*; D011128:Polyradiculopathy / Q000150:complications; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy* / Q000209:etiology
D006993:Hypnotics and Sedatives; D009842:Oligopeptides; D003701:Delta Sleep-Inducing Peptide